What Happened? Shares of automation software company UiPath (NYSE:PATH) jumped 24.2% in the afternoon session after the ...
In another example, a US-managed care provider is using UiPath to tackle a backlog of more than 140,000 provider appeals.
UiPath Inc (NYSE: PATH) stocks surged after reporting strong Q3 results, with Canaccord Genuity analyst raising price target to $19 and Needham maintaining Hold rating.
RBC Capital analyst Matthew Hedberg maintained a Hold rating on UiPath (PATH – Research Report) on May 19 and set a price target of $18.00. The company’s shares closed last Friday at $15.49. Hedberg ...